These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 16438844

  • 21. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME, Gagnon V, Parent S, Asselin E.
    Mol Cancer; 2004 Mar 11; 3():7. PubMed ID: 15016316
    [Abstract] [Full Text] [Related]

  • 22. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J, Lafleur MJ, Parent S, Leblanc V, Asselin E.
    Gynecol Oncol; 2013 Feb 11; 128(2):335-43. PubMed ID: 23174537
    [Abstract] [Full Text] [Related]

  • 23. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct 11; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 24. [Role of suppressor encoprotein PTEN in IGF-1 induced activation of ERK in endometrial carcinoma cells].
    Zhang YJ, Wei LH, Li XP, Wang JL.
    Ai Zheng; 2002 Jul 11; 21(7):724-30. PubMed ID: 12479095
    [Abstract] [Full Text] [Related]

  • 25. LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
    Qiao Q, Li H.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):507-12. PubMed ID: 27381864
    [Abstract] [Full Text] [Related]

  • 26. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M, Gu L, Findley HW, Jiang R, Woods WG.
    Cancer Res; 2003 Oct 01; 63(19):6357-62. PubMed ID: 14559824
    [Abstract] [Full Text] [Related]

  • 27. Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro.
    Shi M, Zhang H, Li M, Xue J, Fu Y, Yan L, Zhao X.
    Gynecol Oncol; 2011 Nov 01; 123(2):387-92. PubMed ID: 21794903
    [Abstract] [Full Text] [Related]

  • 28. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y, Wang C, Yang H, Ma X.
    Eur J Cancer Prev; 2014 Sep 01; 23(5):418-24. PubMed ID: 25068805
    [Abstract] [Full Text] [Related]

  • 29. [Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma].
    Wan XY, Shi YF, Li JQ.
    Zhonghua Zhong Liu Za Zhi; 2004 May 01; 26(5):275-8. PubMed ID: 15312361
    [Abstract] [Full Text] [Related]

  • 30. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells.
    Grünwald V, DeGraffenried L, Russel D, Friedrichs WE, Ray RB, Hidalgo M.
    Cancer Res; 2002 Nov 01; 62(21):6141-5. PubMed ID: 12414639
    [Abstract] [Full Text] [Related]

  • 31. Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer.
    Albitar L, Carter MB, Davies S, Leslie KK.
    Gynecol Oncol; 2007 Jul 01; 106(1):94-104. PubMed ID: 17490733
    [Abstract] [Full Text] [Related]

  • 32. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells.
    Günthert AR, Gründker C, Böttcher B, Emons G.
    Anticancer Res; 2004 Jul 01; 24(3a):1727-32. PubMed ID: 15274347
    [Abstract] [Full Text] [Related]

  • 33. [Activation of phosphatidylinositol 3-kinase-protein kinase B (PI3K-PKB) induced by 17beta-estradiol in endometrial carcinoma cell (Ishikawa)].
    Guo RX, Wei LH, Wang JL, Sun PM, Sun XL.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul 01; 39(7):469-73. PubMed ID: 15347471
    [Abstract] [Full Text] [Related]

  • 34. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
    Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, Sato S, Akeshima R, Terakawa N.
    Clin Cancer Res; 2001 Apr 01; 7(4):892-5. PubMed ID: 11309338
    [Abstract] [Full Text] [Related]

  • 35. The expression of mammalian target of rapamycin in Ishikawa and HEC-1A cells.
    Li X, Xiao L, Yang Y, Shen H, Zeng H, Wang Z.
    J Huazhong Univ Sci Technolog Med Sci; 2008 Jun 01; 28(3):340-2. PubMed ID: 18563337
    [Abstract] [Full Text] [Related]

  • 36. Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells.
    Zhao LJ, Liu N, Li XP, Wang JL, Wei LH.
    Chin Med J (Engl); 2010 May 05; 123(9):1170-5. PubMed ID: 20529558
    [Abstract] [Full Text] [Related]

  • 37. Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway.
    Li SZ, Qiao SF, Zhang JH, Li K.
    Anticancer Agents Med Chem; 2015 May 05; 15(9):1185-9. PubMed ID: 25612678
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA, Thiessen B, Dragowska WH, Daynard T, Bally MB, Dedhar S.
    Oncogene; 2005 May 19; 24(22):3596-605. PubMed ID: 15782140
    [Abstract] [Full Text] [Related]

  • 39. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
    Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH, Baker SJ.
    Cancer Res; 2001 Jun 01; 61(11):4569-75. PubMed ID: 11389092
    [Abstract] [Full Text] [Related]

  • 40. Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression.
    Li H, Hui L, Xu W, Shen H, Chen Q, Long L, Zhu X.
    Pharm Biol; 2012 Oct 01; 50(10):1233-40. PubMed ID: 22957792
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.